Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats.

Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats. Abstract Text:

A E Randolph,T E Mertz,H R Kaplan,

The blood pressure and heart rate effects of a synthetic alkyl ether phospholipid and similar lipids derived from beef heart and egg yolk were studied in normotensive, renal, and spontaneously hypertensive rats. Each agent (1.25 to 10 micrograms/kg) produced a dose-related decrease in blood pressure and increase in heart rate in each model after rapid IV injection. The degree of blood pressure lowering was dependent upon the pretreatment blood pressure. Alkyl ether phospholipid was infused at 10 to 30 micrograms/kg/min to SHR and to platelet depleted SHR; comparable effects (blood pressure decreases and heart rate increases) were noted in both models. Reversal of the epinephrine pressor response was seen in all rats. When administered orally in ascending doses on three consecutive days, 50 and 150 micrograms/kg b.i.d. doses (Day 1 and 2) were inactive whereas 500 micrograms/kg b.i.d. (Day 3) decreased blood pressure by 25 +/- 8 and 21 +/- 8 mm Hg in renal and spontaneously hypertensive rats, respectively. Side effects (by all routes) included limp, cyanotic hind limbs and sedation and were similar in SHR and platelet depleted SHR. Significant, sustained blood pressure lowering was not achieved by any of the alkyl ether phospholipids in the conscious rat models at doses devoid of limiting side effects. The results of these studies show: 1) the BP, HR, and toxic profiles of all three alkyl ether phospholipids were qualitatively similar, 2) at doses causing significant BP lowering there was epinephrine reversal suggesting an alpha-adrenergic blocking component of action, 3) the BP, HR, and toxic effect profiles of alkyl ether phospholipid were comparable in normal and platelet depleted SHR and apparently not platelet-dependent, 4) sustained antihypertensive activity could be achieved by the oral route; however the effects were modest (12 +/- 4% decrease) and associated with limiting side effects.

Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats. Publishing Authors By Initials

AE Randolph,TE Mertz,HR Kaplan,

For similar complex mixtures: tissue extracts research abstracts see: complex mixtures: tissue extracts research

PUBMED ID PMID:

MEDLINE DATE:

Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinical and experimental hypertension. Part A, Th

VOLUME: 5

Page Numbers: 741-58

Journal Abbreviation:

ISSN: 0730-0077

DAY: 12

MONTH: 02

YEAR: 1983

Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8207790

Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats. Keywords Mesh Terms:

KEYWORDS: Tissue Extracts

MESH TERMS: pharmacology

Chemical & Substance for Abstract: Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats. Information

Substance Name: Tissue Extracts

Registry Number: 0

Grant and Affiliation Information for Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Exp Hypertens A

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats Related Publications

• APPL1 associates with TrkA and GIPC1 and is required for nerve growth factor-mediated signal transduction.
• AUA Guidelines and Their Impact on the Management of BPH: An Update.
• Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus.
• Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva.
• Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells.
• Bruton's tyrosine kinase is required for TLR-induced IL-10 production.
• Complications of anterior skull base surgery.
• Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates.
• Embryonic overexpression of the c-Fos protooncogene. A murine stem cell chimera applicable to the study of fibrodysplasia ossificans progressiva in humans.
• Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds.
• Evidence for the multimeric structure of ferroportin.
• Expanding the role of photoselective vaporization of the prostate.
• Exploratory evaluation of several teratogen warning symbols.
• Extracellular matrix remodeling--methods to quantify cell-matrix interactions.
• Factors in Predicting Failure with Medical Therapy for BPH.
• Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome.
• Genome analyses of three strains of Rhodobacter sphaeroides: evidence of rapid evolution of chromosome II.
• Impact of inflammation on ocular immune privilege.
• Laser prostatectomy: checkup on the promises.
• Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
• Medical therapy for benign prostatic hyperplasia: new terminology, new concepts, better choices.
• Mycobacterium leprae inhibits dendritic cell activation and maturation.
• RGD-functionalized bioengineered spider dragline silk biomaterial.
• Sgt1p is a unique co-chaperone that acts as a client adaptor to link Hsp90 to Skp1p.
• Socioeconomic and psychosocial exposures across the life course and binge drinking in adulthood: population-based study.
• Temperament characteristics of street and non-street children in Eldoret, Kenya.
• The mitochondrial citrate transport protein: evidence for a steric interaction between glutamine 182 and leucine 120 and its relationship to the substrate translocation pathway and identification of other mechanistically essential residues.
• The use of botulinum toxin in men with benign prostatic hyperplasia.
• Update on the american urological association guidelines for the treatment of benign prostatic hyperplasia.
• alpha-Blocker Therapy: Current Update.